The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred

Mai, Phuong L.; Friedlander, Michael; Tucker, Kathy; Phillips, Kelly-Anne; Hogg, David; Jewett, Michael A.S.; Lohynska, Radka; Daugaard, Gedske; Richard, Stéphane; Bonaïti-Pellié, Catherine; Heidenreich, Axel; Albers, Peter; Bodrogi, Istvan; Geczi, Lajos; Olah, Edith; Daly, Peter A.; Guilford, Parry; Fosså, Sophie D.; Heimdal, Ketil; Liubchenko, Ludmila; Tjulandin, Sergei A.; Stoll, Hans; Weber, Walter; Easton, Douglas F.; Dudakia, Darshna; Huddart, Robert; Stratton, Michael R.; Einhorn, Lawrence; Korde, Larissa; Nathanson, Katherine L.; Bishop, D. Timothy; Rapley, Elizabeth A.; Greene, Mark H.

doi:10.1016/j.urolonc.2008.10.004

« Previous Next »Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 492-499, September 2010

The International Testicular Cancer Linkage Consortium: A clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred☆

Phuong L. Mai, M.D., M.S.
- Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
- Corresponding author. Tel.: +1-301-496-9928; fax: +1-301-496-1854
Michael Friedlander, M.D.
- Department of Medical Oncology, Division of Medicine, University of New South Wales and Prince of Wales Hospital Randwick, Sydney, Australia
Kathy Tucker, M.B.B.S.
- Department of Medical Oncology, Division of Medicine, University of New South Wales and Prince of Wales Hospital Randwick, Sydney, Australia
Kelly-Anne Phillips, M.D., M.B.B.S.
- Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
David Hogg, M.D.
- Princess Margaret Hospital and University of Toronto, Toronto, Canada
Michael A.S. Jewett, M.D.
- Princess Margaret Hospital and University of Toronto, Toronto, Canada
Radka Lohynska, M.D.
- University Hospital, Department of Radiotherapy and Oncology, Prague, Czech Republic
Gedske Daugaard, M.D., D.M.Sc.
- Department of Oncology, Rigshospitalet, Copenhagen, Denmark
Stéphane Richard, M.D., Ph.D.
- Génétique Oncologique EPHE-CNRS FRE 2939 Faculté de Médecine Paris-Sud; Service d'Urologie, CHU, Le Kremlin-Bicêtre; Institut Gustave Roussy, Villejuif, France
Catherine Bonaïti-Pellié, M.D., Ph.D.
- INSERM U 535, Villejuif, F-94817 France; Univ Paris-Sud, Villejuif, France
Axel Heidenreich, M.D.
- Department of Urology, Division of Oncological Urology, University of Köln, Köln, Germany
Peter Albers, M.D.
- Department of Urology, Klinikum Kassel GmbH, Kassel, Germany
Istvan Bodrogi, M.D.
- Department of Molecular Genetics and Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary
Lajos Geczi, M.D.
- Department of Molecular Genetics and Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary
Edith Olah, Ph.D., D.Sc.
- Department of Molecular Genetics and Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary
Peter A. Daly, M.D.
- Department of Medical Oncology, St James's Hospital, Dublin, Ireland
Parry Guilford, Ph.D.
- Cancer Genetics Laboratory, University of Otago, Dunedin, New Zealand
Sophie D. Fosså, M.D., Ph.D.
- Departments of Clinical Cancer Research and Medical Genetics, Rikshospitalet-Radiumhospitalet, Oslo, Norway
Ketil Heimdal, M.D., Ph.D.
- Departments of Clinical Cancer Research and Medical Genetics, Rikshospitalet-Radiumhospitalet, Oslo, Norway
Ludmila Liubchenko, M.D.
- Laboratory of Clinical Genetics, Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Moscow, Moscow, Russian Federation
Sergei A. Tjulandin, M.D.
- Laboratory of Clinical Genetics, Institute of Clinical Oncology, N.N. Blokhin Russian Cancer Research Center, Moscow, Moscow, Russian Federation
Hans Stoll, R.N., M.Sc.
- Medical Oncology, University Hospital, Basel, Switzerland
Walter Weber, M.D.
- Medical Oncology, University Hospital, Basel, Switzerland
Douglas F. Easton, Ph.D.
- CRC Genetic Epidemiology Unit, Cambridge, United Kingdom
Darshna Dudakia
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Robert Huddart, M.D.
- Academic Radiotherapy Unit, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Michael R. Stratton, M.D., Ph.D.
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Lawrence Einhorn, M.D.
- Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46204, USA
Larissa Korde, M.D., Ph.D
- Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
Katherine L. Nathanson, M.D.
- Division of Medical Genetics, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
D. Timothy Bishop, Ph.D.
- Imperial Cancer Research Fund Genetic Epidemiology Lab, Ashley Wing, Leeds, United Kingdom
Elizabeth A. Rapley, Ph.D.
- Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
Mark H. Greene, M.D.
- Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA

Received 12 August 2008; accepted 1 October 2008. published online 23 January 2009.

To access this article, please choose from the options below

☆ This research was funded in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, and supported by contracts N02-CP-11019 and N02-CP-65504 with Westat, Inc. Other funding includes grant R01 CA114478 (K.L.N.).

PII: S1078-1439(08)00266-4

doi:10.1016/j.urolonc.2008.10.004

Published by Elsevier Inc.

« Previous Next »Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 492-499, September 2010

Access this article on SciVerse ScienceDirect